Howard Capital Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.7K Hold
14,165
﹤0.01% 403
2025
Q1
$19.7K Hold
14,165
﹤0.01% 379
2024
Q4
$24.5K Hold
14,165
﹤0.01% 407
2024
Q3
$28.5K Hold
14,165
﹤0.01% 393
2024
Q2
$31.7K Hold
14,165
﹤0.01% 83
2024
Q1
$40.7K Hold
14,165
﹤0.01% 76
2023
Q4
$25.1K Buy
+14,165
New +$25.1K ﹤0.01% 63